Skip to main content
. 2021 Sep 27;8(1):e000753. doi: 10.1136/bmjgast-2021-000753

Figure 1.

Figure 1

Study flowchart for the training and validation phases. P0L: lymphangiectasia; P0X: xanthomas; P1E: mucosal erosions; P1U: P1 ulcers; P2U: P2 ulcers; P1RS: P1 red spots; P2V: P2 vascular lesions; P1P: P1 protruding lesions; P2P: P2 protruding lesions. The prefixes P0, P1, and P2 refer to the haemorrhagic potential according to Saurin’s classification. AUROC, area under the receiving operator characteristic curve.